Albert Koong
@ackoongmdphd.bsky.social
Physician-scientist, radiation oncologist, cancer biologist.
Division Head and Chair, Radiation Oncology, MD Anderson Cancer Center
#radonc #endcancer
https://scholar.google.com/citations?user=6k_0CuQAAAAJ&hl=en
Division Head and Chair, Radiation Oncology, MD Anderson Cancer Center
#radonc #endcancer
https://scholar.google.com/citations?user=6k_0CuQAAAAJ&hl=en
November 13, 2025 at 1:52 AM
Any guesses regarding where is this location?
November 1, 2025 at 4:10 PM
Any guesses regarding where is this location?
Parents weekend at Brown University!
October 18, 2025 at 1:58 PM
Parents weekend at Brown University!
Excited to share our review of metabolic cell death pathways relevant for cancer therapy. @mdanderson.bsky.social #endcancer
rdcu.be/eK7vV
rdcu.be/eK7vV
Exploiting metabolic cell death for cancer therapy
Nature Reviews Cancer - In this Review, Mao et al. discuss the regulation and interplay of the metabolic cell death pathways ferroptosis, disulfidptosis and cuproptosis and explore how these...
rdcu.be
October 15, 2025 at 3:32 PM
Excited to share our review of metabolic cell death pathways relevant for cancer therapy. @mdanderson.bsky.social #endcancer
rdcu.be/eK7vV
rdcu.be/eK7vV
October 8, 2025 at 11:19 PM
Reposted by Albert Koong
📢 Excited to share our new pub @JCO_ASCO
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
October 4, 2025 at 1:30 PM
📢 Excited to share our new pub @JCO_ASCO
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
That's a wrap! Another #ASTRO25 in the books. Great catching up with everyone. See you in Boston for #ASTRO26! #radonc #endcancer @mdanderson.bsky.social
October 2, 2025 at 9:24 PM
That's a wrap! Another #ASTRO25 in the books. Great catching up with everyone. See you in Boston for #ASTRO26! #radonc #endcancer @mdanderson.bsky.social
October 1, 2025 at 12:31 AM
Reposted by Albert Koong
"MD Anderson is committed to extending our reach to improve cancer care globally," says @schmeler.bsky.social during her #ASTRO25 presentation on identifying international partners when setting up a global oncology program.
Learn more: spr.ly/6013A5Rzf #EndCancer
Learn more: spr.ly/6013A5Rzf #EndCancer
Global Outreach
If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson's appointment process, our information page may be the best place to start.
spr.ly
September 29, 2025 at 1:11 AM
"MD Anderson is committed to extending our reach to improve cancer care globally," says @schmeler.bsky.social during her #ASTRO25 presentation on identifying international partners when setting up a global oncology program.
Learn more: spr.ly/6013A5Rzf #EndCancer
Learn more: spr.ly/6013A5Rzf #EndCancer
At #ASTRO25, MD Anderson experts will present findings from the latest research into radiation oncology.
Learn more: spr.ly/63320Adeji @ackoongmdphd.bsky.social #EndCancer
Learn more: spr.ly/63320Adeji @ackoongmdphd.bsky.social #EndCancer
Top 4 MD Anderson abstracts at ASTRO 2025
At the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, MD Anderson investigators will share new research that may shape the future of radiation oncology. Highlights include long-term data supporting non-surgical treatment options, advances in personalized pain relief and imaging innovations that could make care more precise.
spr.ly
September 26, 2025 at 11:29 PM
Reposted by Albert Koong
"Without this network of mentorship and institutional support, I would not be in the position I am today as a physician-scientist leading my own laboratory," says our Dr. Vincent Bernard-Pagan.
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
4 things I learned from my radiation oncology training at MD Anderson
After completing his radiation oncology residency at MD Anderson and joining the faculty, Vincent Bernard-Pagan, M.D., Ph.D., shares what he learned from his training and what sets MD Anderson apart for trainees.
spr.ly
September 25, 2025 at 8:00 PM
"Without this network of mentorship and institutional support, I would not be in the position I am today as a physician-scientist leading my own laboratory," says our Dr. Vincent Bernard-Pagan.
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
Reposted by Albert Koong
Targeted radiation gave patients with oligometastatic kidney cancer a median of nearly 3 years without systemic therapy while maintaining high survival. A ctDNA biomarker may help personalize this approach. spr.ly/63320ADVdQ #OncSky #EndCancer
Targeted radiation helps patients with kidney cancer delay systemic therapy
Targeted radiation helps patients with kidney cancer delay systemic therapy
spr.ly
September 5, 2025 at 7:00 PM
Targeted radiation gave patients with oligometastatic kidney cancer a median of nearly 3 years without systemic therapy while maintaining high survival. A ctDNA biomarker may help personalize this approach. spr.ly/63320ADVdQ #OncSky #EndCancer
Congrats to these @MDAnderson.bsky.social #radonc faculty for their achievements in these areas. Amazing work to #endcancer!
August 15, 2025 at 1:20 AM
Congrats to these @MDAnderson.bsky.social #radonc faculty for their achievements in these areas. Amazing work to #endcancer!
Congrats to Dr. Prajnan Das for this recognition. This is one of the highest honors bestowed upon @mdanderson.bsky.social faculty. #endcancer #radonc
August 14, 2025 at 10:47 PM
Congrats to Dr. Prajnan Das for this recognition. This is one of the highest honors bestowed upon @mdanderson.bsky.social faculty. #endcancer #radonc
Most recent ranking of scientific journals from Google scholar.
scholar.google.com/citations?vi...
scholar.google.com/citations?vi...
scholar.google.com
August 8, 2025 at 12:00 PM
Most recent ranking of scientific journals from Google scholar.
scholar.google.com/citations?vi...
scholar.google.com/citations?vi...
Thrilled to announce that after a highly competitive national search, Dr. Prajnan Das has been selected as the inaugural chair of GIRO Department @mdanderson.bsky.social . Looking forward to all the great things he will do in this new role. #rad onc #endcancer
June 30, 2025 at 8:34 PM
Thrilled to announce that after a highly competitive national search, Dr. Prajnan Das has been selected as the inaugural chair of GIRO Department @mdanderson.bsky.social . Looking forward to all the great things he will do in this new role. #rad onc #endcancer
Defeated by the grad students in the inaugural @mdanderson.bsky.social #foosball tournament at Zayed. Junjie Chen and I will need to step up our game next year! #radonc #endcancer
June 27, 2025 at 7:57 PM
Defeated by the grad students in the inaugural @mdanderson.bsky.social #foosball tournament at Zayed. Junjie Chen and I will need to step up our game next year! #radonc #endcancer
Subset analysis reveals regional nodal irradiation may be omitted in AXLN pos breast CA with pCR after neoadj chemo. Less may be more. @ibcradiation.bsky.social @fumikochino.bsky.social #radonc
www.nejm.org/doi/10.1056/...
www.nejm.org/doi/10.1056/...
Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy | NEJM
The benefit of regional nodal irradiation in the treatment of breast cancer is well
established for patients with pathologically positive axillary nodes, but whether
it is also beneficial for patie...
www.nejm.org
June 22, 2025 at 2:00 PM
Subset analysis reveals regional nodal irradiation may be omitted in AXLN pos breast CA with pCR after neoadj chemo. Less may be more. @ibcradiation.bsky.social @fumikochino.bsky.social #radonc
www.nejm.org/doi/10.1056/...
www.nejm.org/doi/10.1056/...
Developing effective strategies to overcome acquired resistance to therapy is critical to improving outcomes for #cancer patients.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Acquired resistance in cancer: towards targeted therapeutic strategies - Nature Reviews Cancer
Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni, Knudsen and colleagues discuss t...
www.nature.com
June 20, 2025 at 3:19 AM
Developing effective strategies to overcome acquired resistance to therapy is critical to improving outcomes for #cancer patients.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Congrats to the @mdanderson.bsky.social #radonc class of 2025! Looking forward to all that you will do to #endcancer.
June 19, 2025 at 2:33 AM
Congrats to the @mdanderson.bsky.social #radonc class of 2025! Looking forward to all that you will do to #endcancer.
Congrats to @fumikochino.bsky.social for recent FASCO designation! @mdanderson.bsky.social @astro-org.bsky.social @ascocancer.bsky.social #radonc #endcancer
June 4, 2025 at 10:00 PM
Congrats to @fumikochino.bsky.social for recent FASCO designation! @mdanderson.bsky.social @astro-org.bsky.social @ascocancer.bsky.social #radonc #endcancer
Reposted by Albert Koong
Dr. Christopher Flowers has been honored with ASCO’s Jamie Von Roenn Excellence in Teaching and Mentorship Award. His commitment to mentorship has helped shape the future of cancer research and care. Learn more: www.mdanderson.org/newsroom/asc... #EndCancer #ASCO25 @ascocancer.bsky.social
ASCO: MD Anderson’s Christopher Flowers honored for teaching and mentorship
Christopher Flowers, M.D., division head of Cancer Medicine and chair of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, will be honored with the Jamie Von Roenn Excellence in T...
www.mdanderson.org
May 27, 2025 at 2:19 PM
Dr. Christopher Flowers has been honored with ASCO’s Jamie Von Roenn Excellence in Teaching and Mentorship Award. His commitment to mentorship has helped shape the future of cancer research and care. Learn more: www.mdanderson.org/newsroom/asc... #EndCancer #ASCO25 @ascocancer.bsky.social
So proud of Dr. Manzar, a rising superstar in the #radonc field, specializing in pediatric cancers @mdanderson.bsky.social . #EndCancer #EndChildhoodCancer
May 27, 2025 at 2:57 PM
So proud of Dr. Manzar, a rising superstar in the #radonc field, specializing in pediatric cancers @mdanderson.bsky.social . #EndCancer #EndChildhoodCancer
Faculty Convocation speaker @dglaucomflecken.bsky.social today @mdanderson.bsky.social. Described his own cancer journey using humor and poignant vignettes. Powerful reminder for why science and medicine matters. #endcancer #radonc
May 23, 2025 at 2:54 AM
Faculty Convocation speaker @dglaucomflecken.bsky.social today @mdanderson.bsky.social. Described his own cancer journey using humor and poignant vignettes. Powerful reminder for why science and medicine matters. #endcancer #radonc
Congrats to Ethan Ludmir and Chad Tang for their publication selected for recognition as part of @mdanderson.bsky.social Excellence in Science Award. #radonc #endcancer
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial
PURPOSEThe EXTEND trial tested the hypothesis that adding comprehensive metastasis-directed
therapy (MDT) to chemotherapy would improve progression-free survival (PFS) over chemotherapy
alone among pa...
ascopubs.org
May 18, 2025 at 5:04 PM
Congrats to Ethan Ludmir and Chad Tang for their publication selected for recognition as part of @mdanderson.bsky.social Excellence in Science Award. #radonc #endcancer
ascopubs.org/doi/10.1200/...
ascopubs.org/doi/10.1200/...